High Tide and NuLeaf Naturals Join U.S. National Compassionate Care Council as Founding Members

Rhea-AI Summary

High Tide (Nasdaq : HITI) et sa filiale américaine de CBD dérivé du chanvre NuLeaf Naturals ont rejoint le National Compassionate Care Council des États-Unis en tant que membres fondateurs le 4 mars 2026.

Les entreprises ont déclaré que ce rôle vise à aider à moderniser la politique relative au cannabis médical, à améliorer l accès des patients aux thérapies à base de cannabinoïdes et à apporter leur expertise sectorielle dans le cadre des discussions sur le reclassement fédéral et le remboursement par Medicare.

Parmi les autres membres fondateurs figurent Feals, Medterra, Tilray, Realm of Caring, Lazarus Naturals, Constance CBD et Equilibria.

Key Figures

Current share price: $2.50 52-week range: $1.64–$4.0554 Canadian stores: 219 locations +5 more

8 metrics

Current share price $2.50 Pre-news trading level for HITI

52-week range $1.64–$4.0554 52-week low and high for HITI

Canadian stores 219 locations Canna Cabana retail footprint in Canada

Canadian market share 12% Share across five Canadian provinces

Customer reviews 35,000+ 5-star reviews Verified NuLeaf Naturals e-commerce reviews

Countries licensed 19 countries Remexian import licenses for medical cannabis

Volume vs average 1.39x Today’s volume relative to 20-day average

Market capitalization $221,356,132 Equity value prior to this news

Market Reality Check

Price: $2.50 Vol: Volume 696,531 is 1.39x t...

normal vol

$2.50 Last Close

Volume Volume 696,531 is 1.39x the 20-day average of 501,008, indicating elevated trading interest before this announcement. normal

Technical Shares at $2.50 are trading below the $2.74 200-day MA and sit 38.35% under the 52-week high, while still 52.44% above the 52-week low.

Peers on Argus

Peer momentum signals are mixed: one tracked peer is up (ACB +4.89%), while anot...

1 Up 1 Down

Peer momentum signals are mixed: one tracked peer is up (ACB +4.89%), while another is down (MNDR -5.40%). Broader sector peers in pharmaceutical retail show both gains and losses, suggesting stock-specific drivers rather than a unified sector rotation.

Historical Context

5 past events · Latest: Mar 03 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Mar 03	Board refresh, advisors	Positive	-0.8%	New directors and advisors focused on real estate and artificial intelligence.
Feb 09	Store opening	Positive	+3.0%	New Scarborough Canna Cabana store raises footprint to 219 Canadian locations.
Jan 29	Earnings results	Positive	-8.2%	Record Q4 revenue and EBITDA plus free cash flow and German expansion.
Jan 09	Earnings date notice	Neutral	-0.8%	Announcement of dates for Q4 and full-year 2025 results and webcast.
Dec 23	Year milestone recap	Positive	+0.0%	Recap of 2025 growth, including revenue run-rate and German entry.

Pattern Detected

Recent history shows several positive operational and financial updates followed by flat or negative next-day moves, indicating a tendency toward muted or contrarian reactions to good news.

Recent Company History

Over the past few months, High Tide has emphasized expansion and operational strength. Earnings on Jan 29, 2026 highlighted record quarterly revenue of $164.0M and entry into Germany, yet the stock fell 8.23%. Store growth continued, with a new Canna Cabana bringing the network to 219 locations and that news seeing a 2.98% gain. Governance and AI-focused board refresh in early March 2026 coincided with a modest decline. Today’s NCCC founding membership fits this pattern of strategic positioning and policy engagement.

Market Pulse Summary

This announcement underscores High Tide’s effort to align its U.S. hemp-derived CBD subsidiaries wit...

Analysis

This announcement underscores High Tide’s effort to align its U.S. hemp-derived CBD subsidiaries with evolving federal and state cannabis policy. Joining the NCCC as a founding member ties the company to discussions on Medicare reimbursement and healthcare standards for cannabinoid therapies. In context of recent expansion and record financials, a key watchpoint is how participation in this council eventually affects patient access, regulatory clarity, and utilization of brands like NuLeaf Naturals across the U.S. healthcare landscape.

Key Terms

cannabinoid therapies, medicare reimbursement, cgmP-certified, forward-looking statements

4 terms

cannabinoid therapies medical

"improving patient access to cannabinoid therapies by modernizing healthcare standards"

Treatments that use cannabinoids — chemical compounds found in the cannabis plant or made in a lab — to prevent, relieve, or manage medical conditions. Think of them as a new class of medicines derived from a familiar plant, where effectiveness, legal status, and safety rules vary by country; investors care because clinical results, approval decisions, and changing regulations can quickly alter market size, company value, and risk exposure.

medicare reimbursement regulatory

"explore Medicare reimbursement for hemp-derived cannabinoid products"

Medicare reimbursement is the payment a government health insurance program makes to hospitals, doctors, drugmakers and device makers for covered treatments, drugs or services. Think of it as the price a very large customer agrees to pay a seller; the level and timing of those payments influence how much revenue a health company can earn, how it prices products, and how quickly new treatments are adopted, so changes in reimbursement often directly affect investor returns and risk.

cgmP-certified technical

"Most of NuLeaf's products are produced at its cGMP-certified facility"

cgmp-certified indicates that a company's manufacturing facilities and processes meet current Good Manufacturing Practice standards set by health regulators to ensure products are made consistently, safely and meet quality requirements. For investors, certification lowers the chance of regulatory action, recalls or production stoppages and supports market access and trust—like a restaurant passing a strict health inspection that protects customers and the business.

forward-looking statements regulatory

"CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTSThis press release may contain"

Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

AI-generated analysis. Not financial advice.

CALGARY, AB, March 4, 2026 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, and its leading U.S. hemp-derived CBD subsidiary, NuLeaf Naturals, today announced they have joined the National Compassionate Care Council (NCCC) as founding members.

"Federal cannabis policy in the United States is entering a meaningful transition," said Raj Grover, Founder and Chief Executive Officer of High Tide. "Through our experience building health-focused brands such as NuLeaf Naturals and FAB CBD, we have developed meaningful expertise in serving consumers seeking cannabinoid-based wellness products within a responsible regulatory framework. We are pleased to join the NCCC so that High Tide and NuLeaf can help contribute to the development of thoughtful U.S. federal and state medical cannabis policy, while supporting efforts aimed at improving patient access to cannabinoid therapies across the United States," added Mr. Grover.

The NCCC is dedicated to improving patient access to cannabinoid therapies by modernizing healthcare standards and advancing evidence-based policy. The Council brings together healthcare-focused organizations across the medicinal cannabis sector that prioritize product quality, research, and patient outcomes.

In addition to High Tide and its subsidiaries NuLeaf Naturals and FAB CBD, founding members include Feals, Medterra CBD LLC, Tilray Inc., Realm of Caring, Lazarus Naturals, Constance CBD, and Equilibria.

Recent federal initiatives to reschedule cannabis and explore Medicare reimbursement for hemp-derived cannabinoid products signal a potential shift in U.S. healthcare policy that can have a material impact for High Tide's U.S. based hemp-derived CBD subsidiaries. Through its participation in the NCCC, High Tide aims to contribute industry expertise while supporting broader efforts to expand patient access to safe and effective cannabinoid therapies.

ABOUT HIGH TIDE

High Tide, Inc. is the leading community-grown, retail-forward cannabis enterprise engineered to unleash the full value of the world's most powerful plant. Its wholly owned subsidiary, Canna Cabana, is the second-largest cannabis retail brand globally. High Tide (HITI) is uniquely-built around the cannabis consumer, with wholly-diversified and fully-integrated operations across all components of cannabis, including:

Retail: Canna Cabana™ is the largest cannabis retail chain in Canada, with 219 domestic locations. The Company's Canadian bricks-and-mortar operations span British Columbia, Alberta, Saskatchewan, Manitoba, and Ontario, holding a growing 12% share of the market. In 2021, Canna Cabana became the first cannabis discount club retailer in the world. The Company also owns and operates multiple global e-commerce platforms offering accessories and hemp-derived CBD products.

Medical Cannabis Distribution: Remexian Pharma GmbH is a leading German pharmaceutical company built for the purpose of importation and wholesale of medical cannabis products at affordable prices. Among all German medical cannabis procurers, Remexian has one of the most diverse reaches across the globe and is licensed to import from 19 countries including Canada.

High Tide consistently moves ahead of the currents, having been named one of Canada's Top Growing Companies by the Globe and Mail's Report on Business in 2025 for the fifth consecutive year and was recognized as a top 50 company by the TSX Venture Exchange (the "TSXV") in 2022, 2024 and 2025. High Tide was also ranked number one in the retail category on the Financial Times list of Americas' Fastest Growing Companies for 2023. To discover the full impact of High Tide, visit www.hightideinc.com. For investment performance, don't miss the High Tide profile pages on SEDAR+ and EDGAR.

Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.

ABOUT NULEAF NATURALS

Founded in 2014 in Denver, Colorado, NuLeaf Naturals is one of America's leading cannabinoid companies. Since its inception, the company has been committed to creating the world's highest-quality cannabinoid products in their purest and most potent form. Most of NuLeaf's products are produced at its cGMP-certified facility, enabling it to manufacture ground-breaking cannabinoid formulations while exceeding the highest levels of regulatory compliance. Their cannabinoid products are sold direct-to-consumer from their website and are also available at select bricks-and-mortar stores across the U.S. The company is committed to creating safe, consistent, and effective products and has proudly received over 35,000 verified 5-star customer reviews through its e-commerce platform. 

CONTACT INFORMATION

Media Inquiries
Carter Brownlee
Communications and Public Affairs Advisor
High Tide Inc.
cbrownlee@hightideinc.com
403-770-3080

Investor Inquiries
Vahan Ajamian
Capital Markets Advisor
High Tide Inc.
vahan@hightideinc.com

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This press release may contain "forward-looking information" and "forward-looking statements within the meaning of applicable securities legislation. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company's current belief or assumptions as to the outcome and timing of such future events. The forward-looking statements herein include, but are not limited to, statements regarding: future shifts in U.S. policy, impact on the Corporation's subsidiaries, and outcomes of the coalition. Readers are cautioned to not place undue reliance on forward-looking information. Actual results and developments may differ materially from those contemplated by these statements. Although the Company believes that the expectations reflected in these statements are reasonable, such statements are based on expectations, factors, and assumptions concerning future events which may prove to be inaccurate and are subject to numerous risks and uncertainties, certain of which are beyond the Company's control, including but not limited to the risk factors discussed under the heading "Non-Exhaustive List of Risk Factors" in Schedule A to our current annual information form, and elsewhere in this press release, as such factors may be further updated from time to time in our periodic filings, available at www.sedarplus.ca and www.sec.gov, which factors are incorporated herein by reference. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement and reflect the Company's expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results, or otherwise, or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

View original content to download multimedia:https://www.prnewswire.com/news-releases/high-tide-and-nuleaf-naturals-join-us-national-compassionate-care-council-as-founding-members-302703951.html

SOURCE High Tide Inc.

FAQ

What does High Tide (HITI) joining the NCCC mean for patient access to cannabinoid therapies?

It signals an intent to support broader patient access to cannabinoid therapies in the U.S. According to the company, participation in the NCCC will let High Tide share industry expertise to help modernize healthcare standards and advance evidence-based policy affecting patient access.

Which organizations joined the National Compassionate Care Council alongside High Tide on March 4, 2026?

Founding members include Feals, Medterra, Tilray, Realm of Caring, Lazarus Naturals, Constance CBD, and Equilibria. According to the company, the council unites healthcare-focused cannabinoid organizations prioritizing product quality, research, and patient outcomes.

How might federal rescheduling and Medicare reimbursement developments affect High Tide's U.S. CBD business (HITI)?

These federal initiatives could materially affect High Tide's U.S. hemp-derived CBD subsidiaries' market access and reimbursement. According to the company, such policy shifts may change healthcare and payment pathways for hemp-derived cannabinoid products.

What role will NuLeaf Naturals play as a founding member of the NCCC?

NuLeaf Naturals will contribute expertise on health-focused, hemp-derived cannabinoid products and regulatory compliance. According to the company, NuLeaf brings cGMP manufacturing experience and a focus on product quality and patient outcomes.

Does High Tide describe this NCCC membership as strategic for its U.S. operations (HITI)?

Yes; the company positioned the membership as strategic for shaping U.S. medical cannabis policy and patient access. According to the company, High Tide aims to leverage its wellness-brand experience to influence thoughtful federal and state policy development.